Seminar Series
[Pinn Hall 5023] The Impact of Anti-Drug Antibodies: Phase 3 Immunogenicity Findings and Clinical Implications
Apr
23
23
[Pinn Hall 5023] Designer lipid nanoparticles to probe and reprogram membrane biology
May
7
7